Sustained ERK signaling promotes G2 cell cycle exit and primes cells for whole-genome duplication

Dev Cell. 2024 Jul 8;59(13):1724-1736.e4. doi: 10.1016/j.devcel.2024.03.032. Epub 2024 Apr 18.

Abstract

Whole-genome duplication (WGD) is a frequent event in cancer evolution that fuels chromosomal instability. WGD can result from mitotic errors or endoreduplication, yet the molecular mechanisms that drive WGD remain unclear. Here, we use live single-cell analysis to characterize cell-cycle dynamics upon aberrant Ras-ERK signaling. We find that sustained ERK signaling in human cells leads to reactivation of the APC/C in G2, resulting in tetraploid G0-like cells that are primed for WGD. This process is independent of DNA damage or p53 but dependent on p21. Transcriptomics analysis and live-cell imaging showed that constitutive ERK activity promotes p21 expression, which is necessary and sufficient to inhibit CDK activity and which prematurely activates the anaphase-promoting complex (APC/C). Finally, either loss of p53 or reduced ERK signaling allowed for endoreduplication, completing a WGD event. Thus, sustained ERK signaling-induced G2 cell cycle exit represents an alternative path to WGD.

Keywords: cell cycle dynamics; oncogenesis; signaling dynamics; whole-genome duplication.

MeSH terms

  • Anaphase-Promoting Complex-Cyclosome / genetics
  • Anaphase-Promoting Complex-Cyclosome / metabolism
  • Cyclin-Dependent Kinase Inhibitor p21 / genetics
  • Cyclin-Dependent Kinase Inhibitor p21 / metabolism
  • DNA Damage / genetics
  • G2 Phase / genetics
  • Gene Duplication
  • Genome, Human
  • Humans
  • MAP Kinase Signaling System* / genetics
  • Tumor Suppressor Protein p53* / genetics
  • Tumor Suppressor Protein p53* / metabolism

Substances

  • Tumor Suppressor Protein p53
  • Anaphase-Promoting Complex-Cyclosome
  • Cyclin-Dependent Kinase Inhibitor p21